| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 96.338 | 132.953 | 40.691 | 0 | 0 |
| Total Income - EUR | - | - | - | - | - | 98.524 | 134.145 | 43.684 | 0 | 0 |
| Total Expenses - EUR | - | - | - | - | - | 16.194 | 27.952 | 17.574 | 5.108 | 5.108 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 82.330 | 106.193 | 26.110 | -5.108 | -5.108 |
| Net Profit/Loss - EUR | - | - | - | - | - | 81.444 | 104.864 | 25.703 | -5.108 | -5.108 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Clinical Study Agreements S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 52.308 | 48.720 | 42.089 | 37.224 | 32.535 |
| Current Assets | - | - | - | - | - | 30.618 | 56.962 | 3.659 | 3.704 | 3.789 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 236 | 2.693 | 3.218 | 3.269 | 3.359 |
| Cash | - | - | - | - | - | 30.382 | 54.269 | 441 | 435 | 430 |
| Shareholders Funds | - | - | - | - | - | 81.485 | 104.904 | 25.743 | 20.557 | 15.335 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.441 | 779 | 20.005 | 20.370 | 20.990 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7211 - 7211" | |||||||||
| CAEN Financial Year |
7211
|
|||||||||
Comments - Clinical Study Agreements S.r.l.